Research and development

Research and development

We believe that meticulous scientific research is a prerequisite for all health care. Kaiku Health is developed according to the principles of Evidence-Based Medicine.

KISS. Using Kaiku Health for symptom and QoL tracking of patients treated with immune checkpoint inhibitors targeting PD-1, PD-L1 and CTLA-4 antibodies

Patients are provided with the Kaiku Health web application to report on their symptoms and quality of life in real-time. Algorithms screen the patients’ symptom data and alert the care team according to the severity of symptoms. The study aims to unveil the impact of digital monitoring in managing immune-related adverse events, as well as patient compliance to the new follow-up method.

ePRO-PCaRP/RT. Electrical Patient Reported Outcome of Prostate Cancer ProstaTectomy/RadioTherapy. Randomized Phase III Trial.

Electronic data capture enables the analysis of big data in order to provide personalized care for the patients. Traditionally patients’ quality of life has been measured with paper questionnaires filled during a clinical visit. Objective of the study is to identify the differences and benefits of electronic quality of life follow-up in comparison to traditional method. Also patient experience, efficiency and costs of the electronic data capture will be evaluated. Kaiku Health application is used for the electronic follow-up.

A Novel Digital Patient-Reported Outcome Platform for Head and Neck Oncology Patients

The patient’s role in toxicity reporting is increasingly acknowledged. There is also a need for developing modern communication methods between the patient and the medical personnel. Furthermore, the increasing number of head and neck cancer (HNC) patients is reflected in the volume of treatment follow-up visits, which remains a challenge for the health care. Electronic patient-reported outcome (ePRO) measures may provide a cost-efficient way to organize follow-up for cancer patients.

A collaboration with HUCH Comprehensive Cancer Center and Aalto University: How to use visualizations to communicate the risk of GIST recurrence

Online calculator visualizes the risk of gastrointestinal stromal tumor (GIST) recurrence and helps the doctors to evaluate the need for additional treatment after surgery. GIST Risk calculator is based on a research containing an international sample of 2000 diagnosed GIST-patients published in 2012 by HUCH Cancer Center and Aalto University.

We have several R&D projects and trials in the pipeline.
Stay tuned.

Get in touch

Interested in learning more about Kaiku Health? Send us a note.
This form collects your name and email for communication purposes. Check out our privacy policy for further info on how we protect and manage your submitted data.